ADMA Biologics Inc

ADMA

Equity

ISIN null / Valor 20794750

NASDAQ (2025-11-21)

USD 17.18+5.01%

ADMA Biologics Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

ADMA Biologics Inc is a biopharmaceutical company focused on the development, manufacturing, and commercialization of human plasma-derived immunoglobulins. The company specializes in the collection of human plasma, which is a critical component in the creation of therapies aimed at treating and preventing various diseases. Through its ADMA BioCenters, the company operates a network of FDA-regulated facilities dedicated to the safe and efficient collection of high-quality human plasma. This plasma is then utilized in the production of ADMA's proprietary immunoglobulin products, which are designed to address unmet medical needs in immune-deficient patients and other populations vulnerable to infectious diseases. By controlling the process from plasma collection to product manufacturing, ADMA Biologics ensures a consistent and reliable supply of specialized therapeutic products.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-19.3%1Y

442%3Y

829%5Y

Performance

52.5%1Y

53.6%3Y

58.9%5Y

Volatility